Compare StocksABBV vs CVX

AbbVie Inc. (ABBV) vs Chevron Corporation (CVX): Which Is the Better Buy in 2026?

As of 2026-08-03, ABBV is overvalued at $251, with a DCF intrinsic value of $178 and a margin of safety of -41%. CVX is overvalued at $197, with an intrinsic value of $139 and a margin of safety of -42%. Of the two, ABBV has the wider margin of safety.

ABBV
AbbVie Inc.
$250.94
VS
CVX
Chevron Corporation
$196.83

Rewards

ABBV
  • AbbVie Inc. has maintained ROIC above 10% for 4 consecutive years, suggesting solid business economics.
  • Gross margin of 72.8% indicates strong pricing power — typical of businesses with significant intellectual property or brand strength.
  • AbbVie Inc. scores 82/100 on the Economic Moat Score (Wide Moat), with reinvestment efficiency as the strongest competitive dimension.
CVX
  • PEG ratio of 0.80 suggests the stock is undervalued relative to its growth rate — paying less than 1x for each unit of earnings growth.

Risks

ABBV
  • Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • Free cash flow has declined at a 9.8% CAGR over the past 4 years — a concerning trend.
CVX
  • ROIC has declined by 11.0 percentage points over the past 4 years, which may signal competitive erosion.
  • Buybacks have been poorly timed — 3 out of 4 years involved repurchases at relatively expensive valuations.
  • Trailing P/E of 18.9x is 25% above the historical average of 15.2x — the stock trades at a premium to its own history.

Key Valuation Metrics

Learn more →
ABBV
CVX
Valuation
N/A
Free Cash Flow
N/A
N/A
FCF Yield
N/A
70.89
Trailing P/E
18.94
15.41
Forward P/E
15.41
Quality & Moat
27.60%
ROIC
15.46%
N/A
ROE
6.49%
72.79%
Gross Margin
44.26%
0.41
PEG Ratio
0.80
Balance Sheet Safety
N/A
Net Debt / Equity
0.21
N/A
Interest Coverage
N/A
2.06
Net Debt / EBITDA
0.79
2.76%
Dividend Yield
3.62%
ABBV: 3Ties: 2CVX: 3
ABBVCVX

Historical Fundamentals

Learn more →
ABBV

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

CVX

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

Price ÷ Earnings Per Share — how many years of current earnings you're paying for at today's price. Lower P/E may indicate undervaluation. The dashed forward point is the forward P/E — today's price ÷ analyst consensus EPS.

$1 Retained Earnings Test

Learn more →
ABBV
N/A
Net losses over 3 years — test not applicable
Company had negative cumulative retained earnings
Σ Retained
$-19.85B
Δ Market Cap
+$118.02B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer
CVX
$-2.55
created per $1 retained over 3 years
Market Cap Declined
Σ Retained
$15.44B
Δ Market Cap
$-39.41B
Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Buffett's "$1 Test": For every $1 of earnings retained, has management created at least $1 of market value?
> $1 created per $1 retained = Value Creator · < $1 created = Value Destroyer

Discounted Cash Flow (DCF) Analysis

Learn more →
ABBV
40.7% Overvalued
Price is 40.7% above estimated fair value
Current Price: $250.94
Fair Value: $178.31
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued
CVX
105.4% Overvalued
Price is 105.4% above estimated fair value
Current Price: $196.83
Fair Value: $95.81
Strongly undervalued
Undervalued
Fairly valued
Overvalued
Strongly overvalued

Reverse DCF — Market-Implied Growth

Learn more →
ABBV

Requires positive FCF to compute implied growth rate.

CVX

Requires positive FCF to compute implied growth rate.

Economic Moat Score

Learn more →
ABBV
82/100
Wide Moat
70+ Wide · 40-69 Narrow · <40 None

Wide moat with strength across all dimensions. Reinvestment Efficiency is the standout factor.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.
CVX
43/100
Narrow Moat
70+ Wide · 40-69 Narrow · <40 None

Narrow moat with revenue predictability as the key competitive advantage. Improving roic consistency would strengthen the moat.

Composite score measuring competitive advantage durability across four dimensions: returns above cost of capital, pricing power stability, revenue predictability, and capital efficiency. Based on 4 years of fundamental data.

Forensic Accounting

Learn more →
ABBV
-2.86
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.
CVX
-3.12
Unlikely Manipulator
Above -1.78 = likely manipulator · -2.22 to -1.78 = grey zone

M-Score Trend

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Beneish's 8-variable model estimates the probability of earnings manipulation. An M-Score above -1.78 signals elevated risk — companies in this range have historically been 3-5× more likely to be manipulating earnings. Scores between -2.22 and -1.78 fall in a grey zone warranting further investigation.

Ownership Breakdown

Learn more →
ABBV
Insiders 0.1%Institutions 76.9%Retail & Other 23.0%
No. of Institutional Holders5,146
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.
CVX
Insiders 4.7%Institutions 70.3%Retail & Other 25.0%
No. of Institutional Holders4,952
High insider ownership aligns management incentives with shareholders — a key signal in Buffett-style analysis. Institutional concentration can indicate smart-money conviction but also crowding risk.

High insider ownership aligns management incentives with shareholders. Institutional concentration can indicate smart-money conviction but also crowding risk.

Insider Buying Activity

Learn more →
ABBV
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises
CVX
0
Buys (3M)
0
Buys (12M)
No open market insider purchases found.
Open market purchases · includes direct & indirect ownership · excludes option exercises

Open market purchases · includes direct & indirect ownership · excludes option exercises.

Insider Selling Activity

Learn more →
ABBV
0
Sells (3M)
5
Sells (12M)
Total value (12M): $21.79M
PURDUE DAVID RYAN
Officer
$1.22M
@ $233.56 · 2026-03-04
SIATIS PERRY C.
General Counsel
$4.38M
@ $234.39 · 2026-03-02
SIATIS PERRY C.
General Counsel
$5.15M
@ $230.00 · 2026-02-25
SALEKI-GERHARDT AZITA
Chief Operating Officer
$8.41M
@ $198.42 · 2025-08-12
DONOGHOE NICHOLAS
Officer
$2.64M
@ $198.51 · 2025-08-05
STEWART JEFFREY RYAN
Officer
$12.36M
@ $210.08 · 2025-03-31
REENTS SCOTT T.
Chief Financial Officer
$3.75M
@ $212.34 · 2025-03-14
SIATIS PERRY C.
General Counsel
$5.82M
@ $208.69 · 2025-03-03
GONZALEZ RICHARD A
Director
$20.26M
@ $205.45 · 2025-03-03
RICHMOND TIMOTHY J
Officer
$4.47M
@ $210.45 · 2025-03-03
BUCKBEE KEVIN K
Officer
$3.85M
@ $203.41 · 2025-02-26
RICHMOND TIMOTHY J
Officer
$6.07M
@ $202.90 · 2025-02-26
SIATIS PERRY C.
General Counsel
$1.14M
@ $197.90 · 2025-02-20
BUCKBEE KEVIN K
Officer
$310,032
@ $172.24 · 2024-12-16
GONZALEZ RICHARD A
Officer and Director
$12.40M
@ $186.52 · 2024-08-05
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives
CVX
0
Sells (3M)
25
Sells (12M)
Total value (12M): $216.65M
PATE ROBERT HEWITT
Officer
$8.57M
@ $213.30 · 2026-03-30
PATE ROBERT HEWITT
Officer
$9.07M
@ $192.12 · 2026-03-06
WALZ ANDREW BENJAMIN
Officer
$2.19M
@ $188.58 · 2026-03-02
NELSON MARK A.
Officer
$26.23M
@ $187.92 · 2026-03-02
BONNER EIMEAR P
Chief Financial Officer
$8.60M
@ $187.78 · 2026-03-02
WIRTH MICHAEL K
Chief Executive Officer
$51.62M
@ $189.35 · 2026-03-02
PATE ROBERT HEWITT
Officer
$17.54M
@ $187.67 · 2026-03-02
GUSTAVSON JEFF B.
Officer
$1.24M
@ $186.04 · 2026-02-27
WALZ ANDREW BENJAMIN
Officer
$268,950
@ $183.83 · 2026-02-18
KNOWLES ALANA K.
Officer
$441,327
@ $183.28 · 2026-02-18
BOOTH THOMAS RYDER
Chief Technology Officer
$2.25M
@ $184.21 · 2026-02-13
WALZ ANDREW BENJAMIN
Officer
$122,144
@ $183.40 · 2026-02-12
WALZ ANDREW BENJAMIN
Officer
$3.92M
@ $176.53 · 2026-02-03
BOOTH THOMAS RYDER
Chief Technology Officer
$1.07M
@ $178.43 · 2026-02-03
NELSON MARK A.
Officer
$7.98M
@ $174.17 · 2026-02-02
BONNER EIMEAR P
Chief Financial Officer
$5.62M
@ $175.01 · 2026-01-30
PATE ROBERT HEWITT
Officer
$7.26M
@ $176.40 · 2026-01-30
KNOWLES ALANA K.
Officer
$544,000
@ $170.00 · 2026-01-28
BONNER EIMEAR P
Chief Financial Officer
$1.28M
@ $170.00 · 2026-01-28
KNOWLES ALANA K.
Officer
$537,600
@ $168.00 · 2026-01-14
KNOWLES ALANA K.
Officer
$1.31M
@ $165.05 · 2026-01-05
BONNER EIMEAR P
Chief Financial Officer
$4.68M
@ $165.05 · 2026-01-05
WIRTH MICHAEL K
Chief Executive Officer
$52.27M
@ $162.99 · 2026-01-05
GUSTAVSON JEFF B.
Officer
$1.40M
@ $150.27 · 2025-11-21
KNOWLES ALANA K.
Officer
$636,480
@ $160.00 · 2025-08-29
GUSTAVSON JEFF B.
Officer
$1.42M
@ $152.50 · 2025-02-07
WIRTH MICHAEL K
Chief Executive Officer
$26.36M
@ $160.13 · 2024-11-14
Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives

Direct ownership only · excludes indirect, option exercises, planned (10b5-1) sales & derivatives.

🎭 Mr. Market's Mood

Learn more →
ABBV
FearGreed
😏Greed(61/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.
CVX
FearGreed
😏Greed(67/100)

"Market is optimistic — be cautious and ensure you have a margin of safety"

Composite sentiment score based on 6 market signals. Inspired by Buffett's "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

Composite sentiment score based on market signals. Inspired by Buffett’s "Mr. Market" allegory — fear = potential opportunity, greed = potential risk. Must be used alongside fundamental analysis, not in isolation.

⚖️ Buffett Signal

Learn more →
ABBV
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (61)
CVX
Awaiting DCF Data

The Buffett Signal cross-references market sentiment with DCF valuation. Configure the DCF Analysis above to generate a signal.

DCF Margin of Safety: N/AMr. Market's Mood: Greed (67)
View ABBV Full AnalysisView CVX Full Analysis

Frequently Asked Questions: ABBV vs CVX

Is AbbVie Inc. or Chevron Corporation more undervalued in 2026?

Based on our discounted cash flow model, ABBV trades at a -40.7% margin of safety (intrinsic value $178 vs. price $251), compared to CVX's -41.8% margin of safety (intrinsic $139 vs. $197).

Which stock has a wider economic moat, AbbVie Inc. or Chevron Corporation?

ABBV scores 82/100 (Wide moat), while CVX scores 43/100 (Narrow moat). The moat score measures competitive advantage durability across ROIC consistency, margin stability, revenue predictability, and reinvestment efficiency.

Is AbbVie Inc. in financial distress?

ABBV's Altman Z-Score of 2.4 places it in the Grey zone, signaling elevated bankruptcy risk. CVX scores 3.0 (Safe zone). The Altman Z-Score is a five-factor model that predicts insolvency within two years; scores below 1.81 indicate significant distress.

Which stock has higher return on invested capital, AbbVie Inc. or Chevron Corporation?

ABBV earns 27.6% ROIC versus CVX's 15.5%. A higher ROIC means the company generates more profit per dollar of capital employed, a hallmark of durable competitive advantage in Buffett-style analysis.

Which dividend is safer, AbbVie Inc.'s or Chevron Corporation's?

ABBV's dividend earns a safety score of 39/100 (Unsafe), compared to CVX's 30/100 (Unsafe). ABBV has raised its dividend for 3 consecutive years.

ABBV vs CVX: Which Is the Better Buy in 2026? | SafetyMargin.io